Today's Veterinary Business

AUG 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link:

Contents of this Issue


Page 30 of 75

Feature: Controls osteoarthritis pain and inflammation Benefit: Helps increase quality of life and mobility for dogs Feature: Premium generic at an affordable price Benefit: Costs less than Metacam ® (meloxicam) Feature: Two syringes Benefit: Easily administer exact dose needed for dogs of all weights via syringe MELOXIDYL ® (meloxicam) Help your patients move on to bigger and better things by controlling their pain and inflammation associated with osteoarthritis. DO NOT USE MELOXIDYL ORAL SUSPENSION IN CATS. Acute renal failure and death have been associated with the use of meloxicam in cats. Dogs with known hypersensitivity to meloxicam or other NSAIDs should not receive Meloxidyl Oral Suspension. Meloxidyl Oral Suspension is not recommended for use in dogs with bleeding disorders. If vomiting, diarrhea, decreased appetite or other signs of illness are seen, discontinue treatment immediately. ©2018 Ceva Animal Health, LLC. Meloxidyl is a registered trademark of Ceva Santé Animale S.A. METACAM is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. 1-800-999-0297 See brief summary on page XX.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - AUG 2018